- Investing Ideas
- /
- Hong Kong Pharmaceuticals & Biotech Sustainable Track Record
Hong Kong Pharmaceuticals & Biotech Sustainable Track Record
Results
3
Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.
3 companies
Consun Pharmaceutical Group
Market Cap: HK$10.3b
Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.
1681
HK$12.38
7D
7.7%
1Y
113.8%
Shanghai Henlius Biotech
Market Cap: HK$34.2b
Engages in the research and development of biologic medicines with a focus on oncology, autoimmune diseases, and ophthalmic diseases.
2696
HK$63.00
7D
20.5%
1Y
180.6%
Uni-Bio Science Group
Market Cap: HK$698.6m
An investment holding company, researches and develops, manufactures, and sells biological and chemical pharmaceutical products to treat human diseases in the People’s Republic of China.
690
HK$0.12
7D
8.3%
1Y
98.3%